Skip to main content
Figure 2 | Cancer & Metabolism

Figure 2

From: Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations

Figure 2

Fibroblast growth factor receptor (FGFR)4 deficiency increased the survival of mice with breast tumor. Life spans were scored in days as described in Methods. We monitored 245 Tg and 216 KO-Tg mice. The rates of overall (A) and post breast tumor diagnosis survival (B) in both the FGFR4-deficient and WT mice with TGFα overexpression were determined by Kaplan-Meier analysis. Tg, MMTV-TGFα transgenic; KO, FGFR4 knockout; WT, wild-type; TGFα, transforming growth factor alpha.

Back to article page

Cancer & Metabolism

ISSN: 2049-3002